AEs occurring in >10% in either disease strata, regardless of attribution
. | ET (n = 64) . | PV (n = 50) . | ||
---|---|---|---|---|
. | All grades . | Grade 3+ . | All grades . | Grade 3+ . |
Hematologic | ||||
Anemia | 16 (25.0) | 4 (6.3) | 8 (16.0) | — |
Leukopenia | 13 (20.3) | 1 (1.6) | 11 (22.0) | 2 (4.0) |
Lymphocytopenia | 9 (14.1) | 1 (1.6) | 9 (18.0) | 3 (6.0) |
Neutropenia | 9 (14.1) | 5 (7.8) | 4 (8.0) | 2 (4.0) |
Thrombocytopenia | 6 (9.4) | — | 9 (18.0) | — |
Nonhematologic | ||||
Abdominal pain | 7 (10.9) | — | 2 (4.0) | — |
Alanine aminotransferase | 6 (9.4) | 2 (3.1) | 5 (10.0) | — |
Arthralgia | 9 (14.1) | — | 5 (10.0) | 2 (4.0) |
Bone pain | 7 (10.9) | — | 4 (8.0) | — |
Constipation | 9 (14.1) | — | 7 (14.0) | — |
Cough | 11 (17.2) | — | 4 (8.0) | — |
Cramp | 10 (15.6) | — | 3 (6.0) | — |
Creatinine increased | 1 (1.6) | — | 6 (12) | — |
Depression | 8 (12.5) | — | 4 (8.0) | 1 (2.0) |
Diarrhea | 9 (14.1) | 1 (1.6) | 20 (40.0) | — |
Dizziness | 12 (18.8) | — | 7 (14.0) | — |
Dyspnea | 10 (15.6) | 1 (1.6) | 5 (10.0) | 1 (2.0) |
Edema | 9 (14.1) | — | 9 (18.0) | — |
Fatigue | 28 (43.8) | 1 (1.6) | 20 (40.0) | — |
Flulike symptoms | 11 (17.2) | 1 (1.6) | 9 (18.0) | — |
Headache | 20 (31.3) | 2 (3.1) | 13 (26.0) | 1 (2.0) |
Hyperuricemia | 4 (6.3) | — | 9 (18.0) | — |
Injection site reaction | 13 (20.3) | — | 17 (34.0) | — |
Insomnia | 4 (6.3) | — | 8 (16) | — |
Lightheadedness | 8 (12.5) | — | 1 (2.0) | — |
Myalgia | 10 (15.6) | — | 7 (14.0) | — |
Nausea | 15 (23.4) | — | 12 (24.0) | — |
Pain | 12 (18.8) | 1 (1.6) | 15 (30.0) | 1 (2.0) |
Pruritus | 15 (23.4) | — | 11 (22.0) | — |
Rash | 7 (10.9) | 1 (1.6) | 5 (10.0) | 1 (2.0) |
Upper respiratory infection | 8 (12.5) | — | 4 (8.0) | — |
Urinary tract infection | 7 (10.9) | 1 (1.6) | 5 (10.0) | — |
Vomiting | 2 (3.1) | — | 8 (16.0) | — |
. | ET (n = 64) . | PV (n = 50) . | ||
---|---|---|---|---|
. | All grades . | Grade 3+ . | All grades . | Grade 3+ . |
Hematologic | ||||
Anemia | 16 (25.0) | 4 (6.3) | 8 (16.0) | — |
Leukopenia | 13 (20.3) | 1 (1.6) | 11 (22.0) | 2 (4.0) |
Lymphocytopenia | 9 (14.1) | 1 (1.6) | 9 (18.0) | 3 (6.0) |
Neutropenia | 9 (14.1) | 5 (7.8) | 4 (8.0) | 2 (4.0) |
Thrombocytopenia | 6 (9.4) | — | 9 (18.0) | — |
Nonhematologic | ||||
Abdominal pain | 7 (10.9) | — | 2 (4.0) | — |
Alanine aminotransferase | 6 (9.4) | 2 (3.1) | 5 (10.0) | — |
Arthralgia | 9 (14.1) | — | 5 (10.0) | 2 (4.0) |
Bone pain | 7 (10.9) | — | 4 (8.0) | — |
Constipation | 9 (14.1) | — | 7 (14.0) | — |
Cough | 11 (17.2) | — | 4 (8.0) | — |
Cramp | 10 (15.6) | — | 3 (6.0) | — |
Creatinine increased | 1 (1.6) | — | 6 (12) | — |
Depression | 8 (12.5) | — | 4 (8.0) | 1 (2.0) |
Diarrhea | 9 (14.1) | 1 (1.6) | 20 (40.0) | — |
Dizziness | 12 (18.8) | — | 7 (14.0) | — |
Dyspnea | 10 (15.6) | 1 (1.6) | 5 (10.0) | 1 (2.0) |
Edema | 9 (14.1) | — | 9 (18.0) | — |
Fatigue | 28 (43.8) | 1 (1.6) | 20 (40.0) | — |
Flulike symptoms | 11 (17.2) | 1 (1.6) | 9 (18.0) | — |
Headache | 20 (31.3) | 2 (3.1) | 13 (26.0) | 1 (2.0) |
Hyperuricemia | 4 (6.3) | — | 9 (18.0) | — |
Injection site reaction | 13 (20.3) | — | 17 (34.0) | — |
Insomnia | 4 (6.3) | — | 8 (16) | — |
Lightheadedness | 8 (12.5) | — | 1 (2.0) | — |
Myalgia | 10 (15.6) | — | 7 (14.0) | — |
Nausea | 15 (23.4) | — | 12 (24.0) | — |
Pain | 12 (18.8) | 1 (1.6) | 15 (30.0) | 1 (2.0) |
Pruritus | 15 (23.4) | — | 11 (22.0) | — |
Rash | 7 (10.9) | 1 (1.6) | 5 (10.0) | 1 (2.0) |
Upper respiratory infection | 8 (12.5) | — | 4 (8.0) | — |
Urinary tract infection | 7 (10.9) | 1 (1.6) | 5 (10.0) | — |
Vomiting | 2 (3.1) | — | 8 (16.0) | — |
All data are n (%).